Jun 22, 2026 06:00AM
Jun 15, 2026 06:00AM
May 21, 2026 06:01PM
May 18, 2026 04:30PM
May 14, 2026 06:30AM
May 7, 2026 06:36AM
Apr 7, 2026 07:03AM Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Mar 31, 2026 06:00AM
Mar 24, 2026 07:00AM
Mar 16, 2026 08:08AM
Mar 4, 2026 07:05AM
Feb 20, 2026 07:03AM
Dec 9, 2025 07:00AM
Dec 2, 2025 07:01AM Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
Nov 26, 2025 05:59AM
Nov 19, 2025 07:03AM
Nov 18, 2025 08:30AM
Nov 18, 2025 08:30AM
Nov 17, 2025 04:15PM
Nov 17, 2025 04:15PM
Nov 13, 2025 11:12PM Fennec Pharmaceuticals plans private offering of common shares
Nov 13, 2025 11:11PM
Nov 13, 2025 11:07PM
Nov 13, 2025 11:07PM
Nov 13, 2025 04:08PM
Nov 13, 2025 04:08PM
Nov 13, 2025 04:01PM
Aug 14, 2025 06:08AM Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
Aug 11, 2025 07:12AM
May 13, 2025 06:03AM
May 8, 2025 04:17PM
Mar 10, 2025 06:03AM
Mar 6, 2025 04:22PM
Feb 7, 2025 07:00AM
Dec 20, 2024 06:16AM Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Dec 19, 2024 06:13AM
Dec 12, 2024 07:01AM
Nov 13, 2024 06:27AM
Nov 7, 2024 06:13AM
Oct 31, 2024 06:23AM
Oct 28, 2024 06:23AM
Sep 5, 2024 06:56AM Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 13, 2024 06:05AM
Aug 6, 2024 04:31PM
Aug 5, 2024 06:27AM
Aug 5, 2024 06:26AM
Jul 1, 2024 06:00AM
May 14, 2024 06:03AM
May 7, 2024 06:15PM Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Mar 21, 2024 06:00AM

324,765 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All